The Jockey Club Denies Stud Book Privileges to Four: Blood-Horse 4/19/17

By: BloodHorse Staff The Jockey Club announced one trainer has been denied all privileges of The American Stud Book for 10 years and three other trainers have been denied the same privileges for one or two years. All actions became effective Jan. 1 of this year. The denials of privileges include the privilege of registering

NY Bans Trainer Sedlacek for Five Years: The Blood-Horse 1/26/16

By: Tom Precious Trainer Roy Sedlacek was banned from all racetracks in New York for five years by regulators following what officials said was evidence two horses that ran last October at Belmont Park were administered an opioid analgesic drug nearly as potent as morphine. Sedlacek on Jan. 26 was slapped with a five-year license

Roy Sedlacek suspended for drug positives: Daily Racing Form 11/16/15

By Matt Hegarty Roy Sedlacek, a New York-based trainer, has been suspended indefinitely by New York stewards after two of his horses tested positive for a powerful banned synthetic drug after racing at Belmont Park, according to state records. The two horses tested positive for a rare substance called AH-7921 while racing one week apart

New Synthetic Opioid Designer Drug Found by New York Lab: ARCI 11/9/15

Press Release LEXINGTON, KY - The Association of Racing Commissioners International (ARCI) has put all racing regulatory agencies worldwide on notice of a finding by the New York Equine Drug Testing Program of the presence of AH-7921 in post-race samples taken from horses that recently ran at Belmont Park. This is the first time AH-7921

Two Horses Test Positive for Opioid: The Blood-Horse 11/9/15

By: Blood-Horse Staff The New York State Gaming Commission has indefinitely suspended trainer Roy Sedlacek for two positives in October at Belmont Park for AH-7921, a synthetic opioid the Association of Racing Commissioners International said can be as potent as morphine. The NYSGC scheduled a hearing on the matter for Nov. 10. Samples from Bossmon,

Learn About Our:

Who We Are:

Sign up to receive RMTC communications:

  • Hidden

Sign up to receive RMTC communications:

  • Hidden